.svg)
In our 2023 annual report, Kalderos envisions a drug discount system that creates seamless collaboration, builds mutual understanding and puts the patient at the center of a system that delivers for them. But a number of hurdles stand between drug discount stakeholders and this future. Data silos, outdated technology and ambiguous guidance can ultimately lead to revenue leakage and operational burdens across the board.
In this year’s annual report webinar, Natalie Heck, Kalderos Associate Director, Customer Success Commercial, and Sam Ferber, Kalderos Associate Director, Customer Success Covered Entities, delve into these obstacles and share how Kalderos’ multi-sided platform and covered entity network successfully identify duplicate discounts and build trust among all stakeholders. And for drug manufacturers looking to improve financial forecasting and lift net revenues, you’ll learn how tech-enabled collaboration can help.
In this webinar, we cover:
- The value that stakeholder collaboration can have for drug manufacturers
- How to leverage a powerful combination of relationships and data across the drug discount ecosystem
- How a Drug Discount Management strategy can help manufacturers recover lost revenue
